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ABSTRACT: The successful application of gene therapy relies on the
development of safe and efficient delivery vectors. Cationic polymers such as
cell-penetrating peptides (CPPs) can condense genetic material into
nanoscale particles, called polyplexes, and induce cellular uptake. With
respect to this point, several aspects of the nanoscale structure of polyplexes
have remained elusive because of the difficulty in visualizing the molecular
arrangement of the two components with nanometer resolution. This
limitation has hampered the rational design of polyplexes based on direct structural information. Here, we used super-resolution
imaging to study the structure and molecular composition of individual CPP-mRNA polyplexes with nanometer accuracy. We
use two-color direct stochastic optical reconstruction microscopy (dSTORM) to unveil the impact of peptide stoichiometry on
polyplex structure and composition and to assess their destabilization in blood serum. Our method provides information about
the size and composition of individual polyplexes, allowing the study of such properties on a single polyplex basis. Furthermore,
the differences in stoichiometry readily explain the differences in cellular uptake behavior. Thus, quantitative dSTORM of
polyplexes is complementary to the currently used characterization techniques for understanding the determinants of polyplex
activity in vitro and inside cells.
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Cell-penetrating peptides (CPPs), also known as proteintransduction domains, are a very promising class of vectors
for gene delivery1 because of their ability to facilitate cell entry of
conjugated molecules.2,3 Moreover, because of their positive
charge, CPPs are ideal candidates for the noncovalent
complexation of negatively charged oligonucleotides into
nanosized particles named polyplexes.4 The potential of
polyplexes to deliver different oligonucleotide cargo such as
plasmid DNA or RNA into cells for gene therapy has been
widely explored.5−7 Recently, mRNA has emerged as another
promising option.8−10 Polyplexes of mRNA only need to
penetrate cells and escape from the endosomes or lysosomes to
the cytoplasm, where mRNA gets translated immediately into
proteins. Furthermore, mRNA is only transiently active without
the risk of insertion into the host genome, and it is fully degraded
via physiological mechanisms. Therefore, mRNA-loaded poly-
plexes have recently been proposed as efficient carriers for
oligonucleotide therapy.8−10
Despite the many gene carriers proposed and studied, the
design of the polyplexes is still very challenging, and activity
varies greatly.11 This may also be attributed to the fact that the
structure space of delivery vectors has been navigated with a
limited understanding of the structural properties and variations
of the fabric of a polyplex. In fact, only a handful of methods for
polyplex characterization are currently available. The average
hydrodynamic size and charge of the polyplexes can be
measured using dynamic light scattering (DLS) and zeta
potential or electrophoretic shift assays, respectively.7 Also,
images from electron microscopy (EM) and atomic force
microscopy (AFM) can indicate the polyplex size and shape,12
thus providing information on morphological changes.13,14 The
efficiency of complexation is evaluated using gel electrophoresis
by detecting the presence of free oligonucleotides, while the
affinity is currently measured using a dye exclusion assay.7
Overall, each of the current methods supplies valuable
information; however, they exhibit two main limitations: (i)
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they are mostly ensemble techniques providing average
information for the polyplexes and (ii) they are not able to
distinguish between the two components of the polyplex and
therefore miss quantitative and qualitative aspects of the
composition and inner organization of individual polyplexes.
Therefore, only very limited data is available for composing
molecular models of the structure and the composition of
polyplexes.15−17
Here, we propose the use of two-color direct stochastic optical
reconstruction microscopy (dSTORM) to unveil the structure
and composition of polyplexes on a single-particle basis.
Recently, it has been demonstrated that dSTORM can be
used to image synthetic nanoparticles with different chemical
natures and sizes.18−20 The nanometric resolution, down to 20
nm, provided by this technique together with the possibility to
obtain two-color images is very promising for the character-
ization of multicomponent nanometric assemblies such as
polyplexes. With the appropriate knowledge of the photo-
physical properties of the dye such as the duty cycle and
bleaching rate, STORM provides the possibility to obtain
quantitative information about stoichiometries and absolute
molecule numbers. In this framework, membrane recep-
tors,21−23 DNA origami DNA strands,24 and accessible binding
sites on endocytic/endosomal vesicles25 were quantified.
Therefore, dSTORM can also contribute to the quantitative
understanding of polyplexes. Despite this potential, to the best
of our knowledge, the use of super-resolution for the study of
gene delivery carriers has not been explored.
One of the most important experimental degrees of freedom
in polyplex generation is the ratio of the cationic moiety and
nucleic acids, which determines the N/P ratio, the ratio of
positive over negative charge carriers. The N/P ratio determines
several key properties of the formed polyplexes such as the net
charge, size, and stability.11,26We considered the N/P ratio to be
an ideal test case to establish a direct quantitative analysis of
polyplex composition using super-resolution dSTORM micros-
copy. Gene-delivery carriers consisting of mRNA complexed
with the peptide nona-arginine (R9) were imaged with
molecular resolution. Owing to the ability to simultaneously
measure the size and composition of polyplexes, our results
show both qualitative and quantitative differences in the content
of mRNA and CPPs for different N/P ratios. Moreover,
dSTORM imaging can be performed in a complex matrix, which
allowed us to visualize changes in polyplex structure in blood
serum. This is key information becauase one of the reasons for
the failure of gene carriers in vivo is the lack of stability in blood.
Finally, we demonstrate that the information on polyplex
stoichiometry obtained by STORM readily explains quantitative
differences in the cellular uptake of the polyplexes. Our results
highlight the potential of super-resolution microscopy to play a
pivotal role in the study of polyplexes, complementing the
existingmethodologies and contributing to the rational design of
new structures to enhance cell transfection.
For our dSTORM analysis, we prepared polyplexes formed by
the CPP L-nona-arginine (R9) with a 1929-nucleotide-long
mRNA coding for firefly luciferase. R9 is a well-known cell-
penetrating peptide, and its capacity to complex and induce the
cellular uptake of oligonucleotides has been previously
studied.11,27,28 An overview of our procedure is reported in
Figure 1a. To perform dSTORM imaging, both components
were labeled using the dSTORM-compatible, spectrally well-
separated dyes, AlexaFluor488 and Cyanine 5 for R9 and
mRNA, respectively. The peptide was labeled at the N-terminus.
The mRNA was stochastically labeled with Cy5-UTP with an
average labeling ratio of 27 dyes per molecule, as estimated from
UV/vis absorption measurements (as detailed in Supporting
Information). The labeling ratio (i.e,. the proportion of labeled
molecules) was optimized to obtain an optimal signal density for
dSTORM, as described extensively in the Materials and
Methods section. STORM images of polyplexes with nonlabeled
molecules were obtained as a control, showing almost no
localization (Supporting Information Figure S6). After complex-
Figure 1. Imaging of polyplexes using dSTORM microscopy. (A) Schematic representation of polyplex formation from mRNA-Cy5 and
AlexaFluor488-R9, with imaging and analysis. (B) Conventional fluorescent image of polyplexes at N/P 5 (red represents mRNAmolecules and green
R9 molecules). (C) dSTORM imaging of polyplexes, with the same field of view as in B. Scale bar 2 μm. (D) Close-up images of three different areas
showing low-resolution data on the left and high-resolution data on the right. Scale bar 400 nm.
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ation, the polyplexes were deposited on a glass coverslip for
dSTORM imaging. Figure 1B,C shows representative images of
R9-mRNA polyplexes at an N/P ratio of 5. We had seen before
that well-defined polyplexes were formed for N/P ratios larger
than 3.
The direct comparison between conventional (B) and
dSTORM (C) microscopy images shows how the improvement
of resolution allows individual polyplexes to be resolved, while in
the conventional image it is impossible to distinguish a single
polyplex from clusters. Images revealed complexes of 50−75 nm
in radius, in agreement with DLS measurements (Supporting
Information Figure S7). Interestingly, a large amount of green
signal (which corresponds to the peptide) was not associated
with the polyplexes, indicating that not all of the peptide used in
the complexation procedure was incorporated. This observation
is of special interest as most of the other characterization
methods (e.g., DLS, TEM, AFM, and gel electrophoresis)
cannot detect individual peptides and are strongly biased toward
the macromolecular assemblies. Notably, free cationic moieties
may play a role in the transfection and/or toxicity. As an
example, previous studies of Vaidyanathan et al. proved the
enhanced pDNA endosomal escape of polyplexes due to the
addition of free PEI polymer.29 Moreover, for acylated TP10
analogs, nonincorporated peptide at higher N/P ratios showed
enhanced toxicity.30 Therefore, being able to visualize the
noncomplex materials is of crucial importance.
In addition, dSTORM imaging allowed the study of the
distribution of the peptide and the mRNA within the polyplexes
as magnified in Figure 1D. The observed overlap of the two
colors indicates that mRNA and R9 molecules are homoge-
neously intertwined inside the polyplex, at least within the
resolution of dSTORM. A dSTORM 3D image was acquired to
prove these observations and rule out the effect of the
projection, and a middle stack of a polyplex in Supporting
Information Figure S8 shows that both molecules are indeed
intertwined. This result proves that mRNA molecules are not
exposed on the polyplex surface but are shielded within the
structure. This information is of utmost importance when
designing effective gene delivery systems because confined
mRNA will be more stable than exposed mRNA.31
Having successfully obtained super-resolution images of
polyplexes formed at N/P 5, we further aimed to compare the
structure and distribution of mRNA and R9 molecules for
different N/P ratios. For this purpose, we imaged polyplexes
formed at N/P 1, 3, 5, and 7. The mRNA concentration was
maintained at a constant value in order to follow the
Figure 2. Structure and stoichiometry differences of polyplexes. (A) dSTORM images of polyplexes prepared at N/P ratios of 1, 3, 5, and 7 from left to
right. (B) Frequency histograms of the size of the polyplexes quantified from the STROM images for each N/P ratio. (C) Box plot comparing the
number of localizations of mRNA and peptide quantified for each N/P ratio together with the quantification of single molecules and the number of
localizations obtained from the simulations. Statistical analyses were run (Mann−Whitney test), showing significant differences between the peptide
content in NP3 and NP5 (p < 0.0001) and the mRNA content between NP1 and NP3 (p < 0.0001). Scale bar 200 nm.
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complexation of the same amount of oligonucleotides. In Figure
2A, a representative image of each condition is shown. At N/P 1,
the mRNA-Cy5 signal was not clustered, resulting in more
spread structures compared to the images obtained for N/P 5.
Only minimal mRNA signal colocalized with the Alexa488-R9
signal and mostly free mRNA and free peptides were present,
suggesting that the amount of R9 present at N/P 1 was not
sufficient to condense mRNA into polyplexes. The distribution
of mRNA changed dramatically at N/P 3, for which clear
rounded clusters of mRNA-Cy5 were present. Therefore, we
concluded that the R9 concentration present at N/P 3 was
sufficient to compact the mRNA into polyplexes. The N/P 5 and
N/P 7 polyplexes clearly contained more R9 than the N/P 3
ones. Both N/P 5 and N/P 7 were very similar to each other,
which indicates that the charges in the mRNA were already
saturated and the extra R9 remained in solution and was not
incorporated into the polyplexes. Overall, this qualitative
evaluation of dSTORM images of polyplexes formed at different
N/P ratios provided important structural information regarding
the mRNA and R9 interplay in the formation of polyplexes.
In dSTORM, the image reconstruction is based on single-
molecule localizations detected during the imaging.32 Therefore,
dSTORM provides a highly powerful approach to analyzing the
polyplexes not only qualitatively but also quantitatively.33 Using
an adapted version of a previously developed MatLab script,34
the localizations in the mRNA-Cy5 channel were clustered in
order to remove the free R9 localizations on the glass coverslip
and to provide an estimation of the localizations of mRNA and
CPP molecules at different complexation ratios. (The
procedures are described in the SI.) In Figure 2B, the size of
the polyplexes quantified for each N/P ratio is plotted on a
frequency histogram. The radius of the polyplexes was between
60 and 80 nm under all conditions; however, the polydispersity
of N/P 1 was significantly higher compared to that of the other
ratios. N/P 1 polyplexes had a significant population of
polyplexes exceeding 100 nm in size, indicating that under this
condition most of the mRNAmolecules were not packaged. For
N/P 3 to 7, the formation of polyplexes reduced the size of the
structures, also obtaining more monodisperse populations with
no significant differences between N/P 3 and 7. Notably, for all
conditions, the sizes quantified by dSTORM matched the DLS
ensemble measurements (Supporting Information Figure S7).
In Figure 2C, the median number of localizations per polyplex
detected for each N/P ratio, which is proportional to the
number of molecules of the specific component, is plotted to
unveil the composition of the polyplexes for the different
conditions. More than 15 000 polyplexes were measured per N/
P ratio. The frequency histogram of the number of localizations
is represented in Supporting Information Figures S9−S12.
To better understand the data in Figure 2C, the median
number of localizations per polyplex was plotted together with
two more conditions: (i) polyplexes with only one labeled
mRNA molecule or only one labeled R9 molecule and (ii)
simulated data obtained from a stochastic blinking model. (See
the Supporting Information for further details.) The results for
polyplexes with only one labeled molecule are crucial to
interpreting the data from the measured polyplexes because they
provide a reference for the estimation of the number of
molecules per polyplex (e.g., they distinguish single uncom-
plexed RNA strands from multiple RNAs in a particle). On the
other hand, the simulations can unmask the stochastics of the
dSTORM blinking, one of the main issues of dSTORM
quantification, and provide the possibility to compare the
median number of localizations that was detected experimen-
tally with a theoretical framework. As previously shown,35
stochastic simulations can predict the expected number and
distribution of localizations of a set number of molecules.
Therefore, comparing the number of localizations per polyplex
that were experimentally detected to simulated data can provide
a more accurate estimation of the composition of individual
polyplexes. To obtain the simulated data presented in Figure 2C,
the following steps were performed: (i) we acquired dSTORM
images of polyplexes with a single labeled R9 molecule from
which we estimated the photophysical parameters of the
AlexaFluor488 dye; (ii) we introduced these parameters
together with the known experimental data such as the number
of frames and the number of polyplexes to be simulated; (iii) we
simulated the blinking behavior of a single R9 molecule and
verified that the output number of localizations per cluster
corresponded to the experimental one (detailed information on
the simulation can be found in the Supporting Information); and
(iv) data reported in Figure 2C was obtained by simulating the
blinking behavior of a Poissonian population of polyplexes with
a specific number of peptides. The distributions of simulated and
experimentally detected localizations were compared to
determine which simulated peptide number matched the peak
of the experimental data (e.g., higher peptide numbers for high
N/P ratios). Notably, for mRNA no simulation was conducted
because of the heterogeneous labeling of the mRNA, which
together with the stochastic nature of the detection could not be
approximated.
From the experimental and simulated data presented in Figure
2C, comprehensive information on the polyplex structure and
composition can be obtained. For N/P 1, the number of mRNA
localizations was comparable to that for a single molecule
supporting the hypothesis that single mRNA molecules were
present that were not complexed into polyplexes. For N/P 3, the
experimentally determined median number of mRNA local-
izations significantly increased to about 2 to 3 times that of the
single molecule and remained stable at N/P ratios of 5 and 7.
These results indicate that inside each polyplex there were only a
few mRNA molecules. Interestingly, from N/P 3 to N/P 5 the
box width was enlarged, which indicated a high polydispersity
with respect to the number of encapsulated mRNAs. In contrast,
the density of the peptides followed different behavior compared
to that of the mRNA molecules. At N/P 1, the number of R9
localizations per polyplex was very low and similar to that of a
single peptide. Considering the labeling density (about 1.25% of
labeled peptides weremixed with 98.75% unlabeled ones), this is
compatible with individual mRNA molecules with about 100
peptides attached, an insufficient number to compact the
oligonucleotides into a polyplex. At N/P 3, the number of R9
localizations slightly increased, but it was not until N/P 5 that
the number abruptly grew and remained stable for higher ratios.
At N/P 5 and N/P 7, the box widths were similar and again
larger than that at N/P 3. The median number of simulated
localizations matched the experimental data, demonstrating the
validity of our model. The number of peptides for which the
simulated number of localizations best matched the exper-
imental data was about 25−30 labeled peptides per polyplexes;
considering that 1.25% of the peptides were labeled, we can
estimate approximately 2000−2400 peptides per polyplex. Still,
for N/P 5 and 7 the box plot was broader. The simulated data
always corresponded to the lower range of the plots. The
frequency histograms of the number of localizations in
Supporting Information Figures S9−S11 show the presence of
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a major population in the experimental sample, which fits the
simulated data, together with a tail of polyplexes with a larger
number of molecules that cannot be fitted to the simulated data.
The fact that the experimental data was always broader
demonstrates heterogeneity in the samples, which the
simulation did not recapitulate. Thus, the measured hetero-
geneity cannot be simply explained by the stochastic behavior of
the dye; therefore, it can be concluded that the polyplex
formulation does not consist of a single monodisperse
population but rather of a mixture where polyplexes of different
sizes and RNA quantities coexist.
To summarize these data in a molecular picture, R9 binds
mRNA at N/P 1, but only from N/P 3 is this binding sufficient
to condense the mRNA into polyplexes. Polyplexes from N/P 3
to N/P 7 are similar in size and amount of mRNA but change
significantly with respect to the amount of peptide present in the
particles. Moreover, a significant heterogeneity of the molecular
composition is present, especially at N/P 5 and 7. Notably, the
differences between the last three conditions and the
heterogeneity in the samples would have been difficult or
impossible to measure with other methods, showing the
potential of dSTORM to complement existing technique for
polyplex characterization.
Above, the median number of localizations per component
and condition was analyzed to determine the approximate
number of molecules per polyplex and the polydispersity of the
samples. However, dual-color dSTORM simultaneously pro-
vides information regarding the number of localizations for each
component and the size for each individual polyplex. Figure
3A,B shows a correlative analysis of these three variables. The
scatter plots in Figure 3A represents the data from over 15 000
polyplexes: every dot in the chart represents one polyplex that is
positioned in the graph depending on its amount of R9 or
mRNA localizations. Moreover, every point is plotted in a
different color depending on the size of the polyplex. With this
representation, we can draw conclusions about the relationship
between the size and amount of the two components on a single-
particle basis and thus with respect to the heterogeneity of the
sample. At N/P 1, the mRNA localization is rather
monodisperse compared to that of other samples, corresponding
to the presence of single mRNA molecules. At N/P 3, the
number of mRNA localizations significantly increased as did the
polydispersity of the mRNA content, indicating the existence of
polyplexes with multiple RNA molecules. Moreover, a
correlation between the amounts of R9 and mRNA is present.
This is even more evident for N/P ratios 5 and 7, where the
number of R9 localizations increased overall. In particular, the
polyplexes with higher mRNA localizations are the ones that
show a pronounced increase in the number of R9 localizations.
Following this pattern, at N/P 5 the polyplexes with highmRNA
localizations display an increase in the R9 localizations, and at
N/P 7, a similar correlation was observed, suggesting that the
charges were saturated at N/P 5. These results prove a clear
correlation in the number of molecules of each component
inside individual polyplexes.
Moreover, the color code provides information on the
interplay between composition and size. In all of he N/P
studied, higher amounts of mRNA and R9 were found in larger
polyplexes (green-blue color). The plots in Figure 3B, where the
RNA and R9 content are plotted against size, also confirm this.
However, the data also indicate that the density of the packing
inside the polyplexes must be heterogeneous. Within the size
category of a 65−85 nm radius, polyplexes differ in volume by a
factor of maximally 2.2 while the number of localization varies by
up to a factor of 8. Similarly, with increasing N/P more
localizations for both mRNA and peptide are found for
polyplexes of the same size.
Moreover, we calculated the ratio of R9 localizations per
mRNA localizations and found that it was constant for N/P 1
and 3 but slightly increased with higher radii at N/P 5 and 7
Figure 3.Correlation between the number of mRNA localizations and R9 localizations. (A) Scatter plots of the number of mRNA localizations versus
the number of R9 localizations, together with a color code representing the size for each polyplex. (B) Number of localizations plotted as a function of
polyplex size.
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(Supporting Information Figure S13). These results indicate
that the density of polyplexes prepared at the sameN/P is overall
similar, although there is a trend of higher ratios at higher radii.
Importantly, the estimated number of about 2000 peptides
per polyplex is fully consistent with the increase in mRNA
localizations by about a factor of 3 when going from a single
mRNA molecule to a polyplex. Two thousand peptides
correspond to 18 000 positive charges, which, at an N/P ratio
of 3, can accommodate 6000 negative charges. Because the
mRNA is 1929 nucleotides in length, about 3 mRNA molecules
carry this charge.
Altogether our measurements depict some important
structural aspects of polyplexes: (i) a significant heterogeneity
is present, with polyplexes varying significantly in size and
composition; (ii) a correlation between the two components is
present, with more R9 necessary to pack a higher copy number
of mRNA inside the same polyplexe; and (iii) higher mRNA
content results in larger sizes.
Next, we aimed to assess whether the STORM analyses could
lead to a better understanding of cell biological experiments. For
this purpose, polyplexes were formed with Cy5-mRNA and
fluorescein-labeled R9. We had shown before that fluorescein
and Alexa488-labeled R9 yield equivalent results.36 In this case,
fluorescein-labeled R9 was mixed with unlabeled peptide in a
ratio of 1:10. As confirmed by DLS, polyplexes with diameters
ranging from 70 to 130 nmwere formed for all N/P ratios. HeLa
cells were incubated with polyplexes at constant concentrations
of mRNA, resulting in increasing concentrations of peptide.
These concentrations were proved to be noncytotoxic for cells at
any of the N/P ratios (Supporting Information Figure S14).
Then, intracellular fluorescence was recorded by confocal
microscopy after 1 h of incubation (Figure 4A). For N/P 1,
corresponding to a concentration of fluorescein-labeled peptide
of 0.05 μM, hardly any cell-associated fluorescence could be
detected. FromN/P 3, vesicular fluorescence was presented that
further increased to an N/P ratio of 5 with no further increase to
N/P 7 (Figure 4A). Quantitative image analysis demonstrated
that both the mean intensity of vesicular fluorescence (Figure
4B) and the total number of vesicular pixels per cell as a measure
of the number of endosomes increased from N/P 1 to N/P 5
(Figure 4C). At N/P 1, almost no polyplex was internalized, and
at N/P 3, the amount increased, as it also did at N/P 5 and 7.
These data demonstrate that at N/P 5 the polyplexes had the
right composition to be internalized.
Figure 4. Dependence of cellular nanoparticle uptake on the N/P ratio. HeLa cells were incubated for 1 h with polyplexes consisting of Cy5-mRNA
and fluorescein-labeled R9 at the indicated N/P ratios, followed by washing and confocal microscopy of living cells. Labeled peptide was mixed with
unlabeled peptide in a ratio of 1:10. The mRNA concentration was constant at 4.5 pM for all N/P ratios, corresponding to peptide concentrations of
0.5, 1.5, 2.5, and 3.5 μM for N/P 1, 3, 5 and 7, respectively. (A) Cellular uptake and intracellular distribution. To facilitate the discrimination of
intensities, a false color look-up table has been employed. The scale bar corresponds to 20 μm. (B) Average pixel intensities for vesicular fluorescence.
(C) Pixels per cell as a measure of the number and size of endocytic vesicles. (D) Average pixel intensity for fluorescence outside cells, recorded at a
higher detector gain. (E) Ratio of peptide over mRNA fluorescence intensity. Ratios were calculated for the vesicular intensities of each analysis image
and averaged. Error bars correspond to the standard deviation for normalized data of two independent experiments.
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Even though the cells were washed in order to reduce
extracellular out-of-focus fluorescence, there was still some
fluorescence left. For the peptide, this extracellular fluorescence
strongly increased with increasing N/P ratio, consistent with the
STORM results that had demonstrated the incomplete
incorporation of peptide from N/P ratios larger than 3 (Figure
4D). Moreover, we divided both mean fluorescence intensities
(peptide vs mRNA) to assess the ratio of peptide per mRNA in
the internalized poyplexes (Figure 4E). Interestingly, from N/P
3 to 7 this value remained constant. This observation proves that
a specific composition of the polyplexes is needed to be
internalized by the cells. From our STORM data, we
Figure 5. Stability of polyplexes in serum. (A) dSTORM image of the N/P 5 polyplexes initially and after being incubated with 20% FBS for 1 min and
1 h. Scale bar 200 nm. (B) Number of mRNA localizations of N/P 5 polyplexes after being incubated with 20% FBS for 1 min and 1 h. (C) Number of
R9 localizations of N/P 5 polyplexes after being incubated with 20% FBS for 1 min and 1 h. (D) Schematic representation of the destabilization of the
polyplexes in time in the presence of serum.
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demonstrated that at N/P 3 most of the polyplexes did not have
enough peptide incorporated to pack the mRNA; therefore, we
hypothesis that only a small population of polyplexes at N/P 3
have the right composition, which corresponds to the lower
internalization observed. Finally, the higher ratio at N/P 1 is
consistent with the absence of polyplex formation so that only
free peptide was internalized.
Having established the methodology to measure the polyplex
size and composition, we exploited the ability of dSTORM to
perform analyses in complex media such as blood serum.
Polyplexes are designed to be intravenously injected into the
bloodstream, being in contact with proteins and other
biomolecules that can destabilize the complex. Therefore, it is
of major importance to understand the stability of the polyplexes
in serum. Classically, gel retardation assays are used to assess the
release and decomposition of polyplexes.7 Using dSTORM
imaging, we expected to obtain information on the mechanism
of decomplexation because we were able to track the
composition and size of polyplexes. To this end, we incubated
polyplexes at 37 °C with fetal bovine serum (FBS) at
concentrations of 1, 20, and 100% for 1 min and 1 h followed
by deposition on coverslips. Then, dSTORM images of the
complexes were acquired (Figure 5 and Supporting Information
Figure S15). The behavior of the polyplexes was similar when
incubated with 1 or 20% FBS. Under these conditions, after 1
min the mRNA content in the polyplexes remained stable
compared to the initial composition, indicating that the
polyplexes were not releasing their payload. However, we
observed a decrease in the number of peptide molecules. After 1
min of serum incubation, only half of the initial peptide
localizations were detected. In contrast, after 1 h of FBS
incubation both the numbers of mRNA and R9 molecules
abruptly dropped (Figure 5A−C). Altogether, these results
indicate that the serum proteins interact with the polyplexes in
two stages as schematically represented in Figure 5D: (i) serum
rapidly removes peptides from the polyplexes without
compromising the mRNA compacted inside the particle
(minute timescale) and (ii) proteins destabilize the complexes
causing the release of mRNA molecules (hour timescale). We
envision that the ability of dSTORM to provide additional
information about the mechanism of polyplex disassembly will
support the study and design of gene carriers with improved
serum stability.
We presented an in-depth study of the structure and
composition of polyplexes containing mRNA and cell-
penetrating peptide R9 using dSTORM imaging. Our results
show both qualitative and quantitative differences in the mRNA
and peptide content of individual polyplexes formed at different
N/P ratios. Importantly, a minimum excess of peptide was
required to condense the mRNA into polyplexes because at N/P
1 no distinct clusters could be observed. At N/P 3, the number
of peptides was sufficient to pack the mRNA into compact
polyplexes. With an increase in N/P, the R9 content and peptide
to mRNA ratio in the polyplexes further increased, reaching a
plateau at around N/P 5. The possibility to image individual
polyplexes allowed us to dissect the relationship between the
relative content of the two components and the size of the
polyplexes, demonstrating a next-to-positive correlation of both
components with respect to size, some heterogeneity in the
packing density, and an increase in the packing density with
increasing N/P ratio. Our analyses clearly demonstrate that the
insights gained through the STORM analysis of the polyplexes
directly translate into a better understanding of cellular uptake
experiments. From N/P 5 to 7, the characteristics of the
polyplexes are the same, which explains why they have the same
cellular uptake efficiency. At N/P 3, sufficient mRNA
encapsulation had been achieved for only a fraction of the
polyplexes as evident from the large heterogeneity of polyplexes
at the molecular level, demonstrated by STORM. Finally, the
imaging of the destabilization of polyplexes in the presence of
serum provided mechanistic insights into the disassembly
mechanism, a crucial aspect for the in vivo performance of
gene carriers. Our study highlights the potential of multicolor
super-resolution microscopy to shed new light on the nanoscale
structure and stoichiometry of polyplexes, a key aspect for the
understanding of gene delivery carriers. Future perspectives
include a study of structure−activity relationships for a variety of
polymeric, lipidic, and peptidic carriers and a study of the
structure of polyplexes in cells after internalization. In this
framework it has to be considered that STORM imaging is
possible only in fixed cells and therefore optimization of the
fixation procedure to retain the polyplex structure is necessary.
In conclusion, we believe that super-resolution microscopy can
nicely complement the current techniques for polyplex
characterization contributing to the guidance of the design of
more effective oligonucleotide therapeutics.
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